Sunday, February 12, 2012

Site Search

2nd Imaging in Drug Development conference 23rd & 24th of January 2008, London, UK

Following on from the success of the 2007 Imaging in Clinical Trials meeting, ACI is proud to introduce the 2nd Imaging event – Imaging in Drug Development Conference.

The conference will address the latest advances and key issues driving the application of imaging technologies and techniques in preclinical and clinical drug development.
The Agenda

Throughout the 2 days you will have the opportunity to hear from your industry peers and discover the hottest developments in the employment of imaging techniques in drug development:

· Determine the importance of imaging in therapy monitoring

· Consider key strategies in image data handling and analysis

· Discover the developments in the integration of imaging biomarkers in preclinical and clinical studies

· Examine the role of imaging across therapeutic areas – including oncology, cardiology and CNS

· Understand the challenges in translating from bench to bedside through imaging

· Learn more about the role of nuclear medicine in the preclinical phase

An Interactive 2 Days

ACI’s meetings offer the perfect opportunity to discover the latest updates and to discuss your own research challenges and solutions with your peers through an interactive and informative 2 day programme.
· Hear from an outstanding line-up of the sector’s leading researchers involved in industry and academia – and leading the field in imaging studies

· Network informally with a relatively small, targeted group of senior-level researchers, executives and decision-makers from the pharmaceutical and biotechnology industries
· Learn more about your peers’ research, network with key industry leaders and your industry colleagues

· Discuss the latest challenges and developments in this rapidly changing and growing sector of the industry

· Participate in roundtable sessions – giving you the chance to discuss the latest issues with your colleagues – and the speakers – in an open, informal and intimate setting.

Thanks to our PartnersAcademy of Molecular Imaging ; Future Drugs ; Next Generation Pharmaceutical ; Pharma Marketletter ; PharmiWeb ; Biophotonics International ; Clinical Contract Research Association ; PharmaVoice ; World Pharmaceutical Frontiers ; Clinical Contract Research Association ; Pharmaceutical Technology; HT Screenings ; GenomicsProteomics.com ; Labnews ; Drug Development Technology ; American Pharmaceutical Reviews